Latest current cash for CERO: $940K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), CERO shows a current cash of $940K. That compares with $3.3M in the prior-year period — down 71.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CERO's current cash is now $940K (was $3.3M) — a 71.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether CERo Therapeutics Holdings is outperforming or lagging.
Tracking CERO's current cash over time shows whether CERo Therapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $940K That compares with $3.3M in the prior-year period — down 71.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has CERo Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $940K) with ownership activity and broader fundamentals.